Anu Patel

MedicineComputer SciencePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data”.

Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data

iScience(2025)10.1016/j.isci.2025.111932

N/A

0.241DataRank · unranked

4 citations

Anu Patel, Bernard Ngara, Rob C. van Wijk, Natasha Strydom, Qianwen Wang +9 more

Calculating Pharmacokinetic Areas

Research Square(2022)10.21203/rs.3.rs-1934171/v1

N/A

0DataRank · unranked

0 citations

Anu Patel, Hirokazu Wakuda, Ava Y Xu, Leslie Z. Benet

Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3201

N/A

0DataRank · unranked

7 citations

Sarah B. Doernberg, Travis Zack, Atul Janardhan Butte, Kendra K. Radtke, Anu Patel

Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification

International Journal of Antimicrobial Agents(2024)10.1016/j.ijantimicag.2024.107404

N/A

0DataRank · unranked

2 citations

Geraint Davies, Elin M. Svensson, Derek J. Sloan, Andrew D. McCallum, Anu Patel +4 more

Lesion penetration predicts tuberculosis regimen success: a validated translational tool for de-risking late-stage drug development

Research Square(2025)10.21203/rs.3.rs-6890010/v1

N/A

0DataRank · unranked

0 citations

Jacqueline P. Ernest, Annamarie E. Bustion, Anu Patel, Jansy P. Sarathy, Firat Kaya +9 more